Food allergy and eosinophilic esophagitis: Oral immunotherapy reveals a disease in flux
- PMID: 39954946
- PMCID: PMC12317832
- DOI: 10.1016/j.anai.2025.02.007
Food allergy and eosinophilic esophagitis: Oral immunotherapy reveals a disease in flux
Conflict of interest statement
Disclosures The authors have no conflicts of interest to report.
References
-
- Morales-Cabeza C, Infante S, Cabrera-Freitag P, Fuentes-Aparicio V, Zubeldia JM, Alvarez-Perea A. Oral Immunotherapy and Risk of Eosinophilic Esophagitis in Children: 15 Years’ Experience. J Pediatr Gastroenterol Nutr 2023; 76:53–8. - PubMed
-
- Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2014; 113:624–9. - PubMed
-
- Nilsson C, Scurlock AM, Dellon ES, Brostoff JM, Pham T, Ryan R, et al. Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy. J Allergy Clin Immunol Pract 2021; 9:4496–501. - PubMed
-
- Petroni D, Spergel JM. Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy. Ann Allergy Asthma Immunol 2018; 120:237–40 e4. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
